Results 121 to 130 of about 21,132 (237)
Diabetic Gastroparesis and Glycaemic Control.
, 2019 PURPOSE OF REVIEW: Gastroparesis is an important complication of diabetes that may have a major impact on the quality of life as a result of upper gastrointestinal symptoms and impaired glycaemic control.
Rayner, C.K. +4 more
core +1 more source
JCRPEGastroparesis is a long-term complication of diabetes related to autonomic neuropathy. It is characterized clinically by delayed gastric emptying and upper gastrointestinal symptoms, including early satiety, postprandial fullness, nausea, vomiting, and ...
Fortunato Lombardo +8 more
doaj +1 more source
Therapeutic applications of ghrelin agonists in the treatment of gastroparesis
, 2015 There remains an unmet need for effective pharmacologic treatments for gastroparesis. Ghrelin is the endogenous ligand for the growth hormone secretagogue receptor and has been shown to regulate energy homeostasis and exert prokinetic effects on ...
Wo, John M., Shin, Andrea
core +1 more source
Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives
, 2013 Introduction: Gastroparesis is an important clinical disorder characterised by delayed gastric emptying in the absence of mechanical outlet obstruction. Idiopathic, diabetes and postsurgical causes represent the most common aetiologies.
Jones, K. +3 more
core +1 more source
INTRODUCTION: Cannabinoids are being explored as potential treatments for gastroparesis due to their anti-emetic, gastric motility modulation, appetite stimulation, and analgesic properties coupled with their increasing use due to legalization in many ...
Madi, Mahmoud Y +6 more
core
Gastroparesis and the current use of prokinetic drugs
, 1993 Gastroparesis is a chronic gastric motility disorder in which there is delayed gastric emptying of solids plus or minus liquids. Symptoms of gastroparesis may range from early satiety and nausea in mild cases to chronic vomiting, dehydration, and ...
McCallum, R W, Kendall, B J
core
Prevalence and clinical determinants of diabetic gastroparesis in type 2 diabetes: a symptom- and scintigraphy-based cross-sectional study. [PDF]
BMC GastroenterolAbokresha MM +4 more
europepmc +1 more source
Evolving prokinetic therapy: New targets and therapeutic opportunities in gastrointestinal motility disorders. [PDF]
World J Gastrointest Pharmacol TherGoyal O +10 more
europepmc +1 more source
Alternative Therapeutic Approaches in the Management of Gastroparesis: A Systematic Review. [PDF]
DiseasesTan D, Singh S, Krishnan U, Ho V.
europepmc +1 more source